Gastroenterology , Hepatology
Optimizing Hepatic Encephalopathy Care Across Settings: Standardized Tools for Hospital and Home
DURATION
1 hr
PROFESSION
Physician, Nursing, Pharmacy, Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2026-06-16
Hepatic encephalopathy (HE) is a serious complication of cirrhosis that contributes to cognitive decline, frequent hospitalizations, and care challenges post-discharge. This 60-minute MOC Section 1–accredited webinar delivers practical, evidence-based strategies to improve HE management in hospitalized patients—from timely diagnosis and treatment with lactulose and rifaximin to optimizing discharge planning with standardized order sets and patient support programs (PSPs). Through real-world scenarios and clinical best practices, participants will learn how to streamline care, reduce recurrences, and improve outcomes across transitions.
This program has received financial support from Lupin Pharma Canada in the form of an unrestricted educational grant.
Faculty
- Karim Qumosani, MD, PCME, ABIM, FRCPC
- Vladimir Marquez, MDCM M.Sc, FRCPC
- Magnus McLeod, BSc, MD, FRCPC, DRCPSC
Learning objectives
Upon completion of this continuing education, program participants will be better able to:
- Describe the epidemiology, clinical burden, and care transition challenges associated with hepatic encephalopathy (HE)
- Discuss hospital-based management of HE, including the first-line use of lactulose and adjunctive use of rifaximin, as well as strategies to ensure treatment continuity post-discharge
- Implement a hospital order set for HE management to improve patient outcomes through streamlined protocols and coordinated care
Accreditation
This co-developed activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved and co-developed by the Queen's University CPD Team. You may claim a maximum of 1 hour (credits are automatically calculated).
Session ID: 00017955.
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Physician, Nursing, Pharmacy, Specialist
Profession
1
# of credits
Learning Objectives
Upon completion of this continuing education, program participants will be better able to:
- Describe the epidemiology, clinical burden, and care transition challenges associated with hepatic encephalopathy (HE)
- Discuss hospital-based management of HE, including the first-line use of lactulose and adjunctive use of rifaximin, as well as strategies to ensure treatment continuity post-discharge
- Implement a hospital order set for HE management to improve patient outcomes through streamlined protocols and coordinated care
MOC - Section 1
ACCREDITATION
Gastroenterology , Hepatology
Learning Category
Hepatic Encephalopathy
Topic
0
Price
2026-06-16
Expiry Date
CAN-eng
Region/Language
Course Description
Hepatic encephalopathy (HE) is a serious complication of cirrhosis that contributes to cognitive decline, frequent hospitalizations, and care challenges post-discharge. This 60-minute MOC Section 1–accredited webinar delivers practical, evidence-based strategies to improve HE management in hospitalized patients—from timely diagnosis and treatment with lactulose and rifaximin to optimizing discharge planning with standardized order sets and patient support programs (PSPs). Through real-world scenarios and clinical best practices, participants will learn how to streamline care, reduce recurrences, and improve outcomes across transitions.
This program has received financial support from Lupin Pharma Canada in the form of an unrestricted educational grant.
Faculty
- Karim Qumosani, MD, PCME, ABIM, FRCPC
- Vladimir Marquez, MDCM M.Sc, FRCPC
- Magnus McLeod, BSc, MD, FRCPC, DRCPSC
Accreditation
This co-developed activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved and co-developed by the Queen’s University CPD Team. You may claim a maximum of 1 hour (credits are automatically calculated).
Session ID: 00017955.
1 hr
Duration
0
Price
1
# of credits
